Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
Omidenepag isopropyl eye drops may increase nearsightedness in patients with glaucoma, leading to myopic shifts of 0.75 D or more, according to a study published in Journal of Glaucoma.
“Omidenepag isopropyl is a relatively new glaucoma medication that works differently from traditional prostaglandin analogs,” study author Jin-Soo Kim, MD, associate professor in the department of ophthalmology at Chungnam National University Sejong Hospital, Korea, told Healio. “While it has the advantage of avoiding prostaglandin-associated periorbitopathy, there have been reports of side